Two Sigma Advisers LP increased its stake in shares of Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) by 575.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 74,300 shares of the company's stock after buying an additional 63,300 shares during the quarter. Two Sigma Advisers LP owned 0.23% of Bowhead Specialty worth $2,639,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also modified their holdings of BOW. SG Americas Securities LLC bought a new position in shares of Bowhead Specialty during the 4th quarter worth approximately $344,000. Rhumbline Advisers raised its position in Bowhead Specialty by 89.5% in the 4th quarter. Rhumbline Advisers now owns 12,601 shares of the company's stock valued at $448,000 after purchasing an additional 5,953 shares during the last quarter. Peregrine Capital Management LLC raised its position in Bowhead Specialty by 143.3% in the 4th quarter. Peregrine Capital Management LLC now owns 295,723 shares of the company's stock valued at $10,504,000 after purchasing an additional 174,172 shares during the last quarter. New York State Common Retirement Fund bought a new position in Bowhead Specialty in the 4th quarter valued at $64,000. Finally, Alberta Investment Management Corp raised its position in Bowhead Specialty by 64.3% in the 4th quarter. Alberta Investment Management Corp now owns 147,032 shares of the company's stock valued at $5,223,000 after purchasing an additional 57,554 shares during the last quarter.
Bowhead Specialty Price Performance
Shares of NYSE BOW traded up $0.13 during midday trading on Friday, hitting $37.29. The stock had a trading volume of 152,033 shares, compared to its average volume of 199,733. The company's 50-day simple moving average is $39.22 and its 200 day simple moving average is $35.97. The firm has a market cap of $1.22 billion and a P/E ratio of 28.47. Bowhead Specialty Holdings Inc. has a fifty-two week low of $23.70 and a fifty-two week high of $42.29.
Bowhead Specialty (NYSE:BOW - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.34 EPS for the quarter, beating the consensus estimate of $0.33 by $0.01. The firm had revenue of $174.85 million during the quarter, compared to analyst estimates of $105.17 million. Equities analysts expect that Bowhead Specialty Holdings Inc. will post 1.36 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on BOW shares. Keefe, Bruyette & Woods lifted their price objective on Bowhead Specialty from $43.00 to $45.00 and gave the company an "outperform" rating in a research report on Friday, May 9th. Morgan Stanley lifted their price objective on Bowhead Specialty from $36.00 to $39.00 and gave the company an "equal weight" rating in a research report on Monday, May 19th. JMP Securities lifted their price objective on Bowhead Specialty from $38.00 to $40.00 and gave the company a "market outperform" rating in a research report on Friday, April 11th. Piper Sandler started coverage on Bowhead Specialty in a research report on Wednesday, April 16th. They issued an "overweight" rating and a $44.00 price objective for the company. Finally, JPMorgan Chase & Co. lifted their price objective on Bowhead Specialty from $30.00 to $35.00 and gave the company a "neutral" rating in a research report on Tuesday, April 8th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $39.67.
View Our Latest Research Report on BOW
Bowhead Specialty Profile
(
Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Featured Articles

Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.